Table 2.

Conventional 2D and TDI echocardiographic measurements by treatment group

Echocardiographic parameter	Treatment Group	Pre-Treatment (± SD)	Post-Treatment (± SD)	P-value
LVIDd indexed cm/m2	Clofarabine	2.28 (±0.28)	2.26 (±0.23)	0.74
	7+3	2.41 (±0.42)	2.39 (±0.42)	0.37
LVEF (Simpson’s biplane)	Clofarabine	0.64 (±0.06)	0.58 (±0.08)	0.19
	7+3	0.61 (±0.08)	0.57 (±0.08)	0.09
Mitral E wave velocity cm/s	Clofarabine	82.52 (±19.12)	80.50 (±23.19)	0.74
	7+3	90.65 (±21.87)	77.20 (±15.92)	0.015
Mitral A wave velocity cm/s	Clofarabine	79.29 (±16.52)	85.83 (±21.37)	0.07
	7+3	81.32 (±23.18)	78.31 (±23.19)	0.60
E/A	Clofarabine	1.06 (±0.25)	0.95 (±0.20)	0.55
	7+3	1.25 (±0.63)	1.10 (±0.41)	0.11
Deceleration time ms	Clofarabine	243 (±153.8)	230 (±45.2)	0.55
	7+3	232.31 (±98.03)	200.77 (±53.81)	0.70
Mitral Septal s’ wave velocity cm/s	Clofarabine	8.66 (±1.32)	9.6 (±3.37)	0.64
	7+3	9.24 (±2.74)	6.97 (±1.42)	0.051
Mitral Septal e’ wave velocity cm/s	Clofarabine	9.01 (±2.44)	7.8 (±2.93)	0.58
	7+3	7.91 (±1.73)	6.34 (±1.45)	0.002
Mitral Septal a’ wave velocity cm/s	Clofarabine	11.05 (±1.50)	12.12 (±4.19)	0.44
	7+3	11.24 (±2.59)	11.12 (±3.03)	0.42
Mitral Lateral s’ wave velocity cm/s	Clofarabine	9.17 (±1.88)	9.17 (±2.49)	0.44
	7+3	9.87 (±3.59)	7.8 (±1.96)	0.13
Mitral Lateral e’ wave velocity cm/s	Clofarabine	10.93 (±2.04)	9.46 (±2.49)	0.41
	7+3	10.21 (±2.00)	9.29 (±1.48)	0.16
Mitral Lateral a’ wave velocity cm/s	Clofarabine	12.36 (±2.36)	11.38 (±1.91)	0.33
	7+3	12.13 (±3.06)	11.13 (±4.56)	0.10
RV basal diameter	Clofarabine	2.97 (±0.47)	2.94 (±0.69)	0.55
	7+3	3.01 (±0.50)	3.11 (±0.69)	0.46
TAPSE	Clofarabine	2.23 (±0.45)	2.14 (±0.21)	0.54
	7+3	2.30 (±0.64)	2.20 (±0.38)	0.99